Renew Biotechnologies
May 21, 2024
Renew BioTechnologies is dedicated to exploring and embracing groundbreaking biotechnologies and intellectual property. With a remarkable knack for capturing market share, Renew excels in leveraging its cutting-edge technologies and spearheads innovation in the field. Renowned for its strategic alliances and sponsored research agreements with leading universities, Renew consistently enjoys a robust pipeline of exciting new biotech projects, propelling the frontiers of scientific progress.
Recent News
- The 2025 Wilson Sonsini E&I Summit Attracts Over 400 Participants
- First Patient Enrolled in Merit Medical’s PREEMIE Study
- iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia
- Altitude Lab Demo Day
- Steve Pacelli Appointed CEO of Epitel, Inc.
- Sera Prognostics Announces Pricing of $50 Million Public Offering
